Literature DB >> 5321480

Interference with valine and isoleucine biosynthesis by cyclic hydroxamic acids.

R W Hogg, C S Biswas, H P Broquist.   

Abstract

Hogg, Robert W. (University of Illinois, Urbana), Chitra S. Biswas, and Harry P. Broquist. Interference with valine and isoleucine biosynthesis by cyclic hydroxamic acids. J. Bacteriol. 90:1265-1270. 1965.-The introduction of a hydroxyl group in a number of common barbiturates, a substitution which converts these compounds to cyclic hydroxamic acids, gives rise to compounds which inhibit growth of Escherichia coli. The toxicity of these hydroxybarbiturates appears to be associated, at least in part, with interference with valine and isoleucine biosynthesis, as a combination of these amino acids counteracts their toxicity. A subinhibitory level of 1-hydroxy-5-ethyl-5-isopropylbarbituric acid (hydroxyipral) was counteracted either by valine or by its early precursor, alpha-acetolactate, and led to a study of the effect of these cyclic hydroxamic acids on acetolactate synthesis in a cell-free enzyme system of E. coli. In this system, the parent barbiturates and their respective hydroxy derivatives were only moderately active in blocking acetolactate synthesis. Detailed kinetic studies of the most active compound, hydroxyipral showed no obvious relationship to the substrate or cofactors of the system. The inhibitory effects of hydroxyipral, either on growth of E. coli or in the acetolactate-forming system, could not be counteracted by Fe(++), but the toxic effect of aspergillic acid and o-phenanthroline in these instances was reversed by Fe(++), which implies an iron involvement in the acetolactate-forming system of E. coli.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5321480      PMCID: PMC315811          DOI: 10.1128/jb.90.5.1265-1270.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  6 in total

1.  Isoleucine and valine metabolism in Escherichia coli. VIII. The formation of acetolactate.

Authors:  H E UMBARGER; B BROWN
Journal:  J Biol Chem       Date:  1958-11       Impact factor: 5.157

2.  Biosynthesis of aspergillic acid.

Authors:  J C MACDONALD
Journal:  J Biol Chem       Date:  1961-02       Impact factor: 5.157

3.  Isoleucine and valine metabolism in Escherichia coli. X. The enzymatic formation of acetohydroxybutyrate.

Authors:  R I LEAVITT; H E UMBARGER
Journal:  J Biol Chem       Date:  1961-09       Impact factor: 5.157

4.  Studies on Antibacterial Products Formed by Molds: I. Aspergillic Acid, a Product of a Strain of Aspergillus Flavus.

Authors:  E C White; J H Hill
Journal:  J Bacteriol       Date:  1943-05       Impact factor: 3.490

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.